Treatment of recurrent pediatric myelodysplastic syndrome post hematopoietic stem cell transplantation
CLINICAL CASE REPORTS(2023)
摘要
Treatment of recurrent myelodysplastic syndrome (MDS) after hematopoietic cell transplantation (HCT) remains challenging. We present a 4-year-old girl experiencing early MDS relapse post-HCT treated with a multimodal strategy encompassing a second HCT and innovative targeted therapies. We underscore the potential of a comprehensive treatment approach in managing recurrent pediatric MDS. image
更多查看译文
关键词
disease control,hematopoietic stem cell transplantation,myelodysplastic syndromes,relapse
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要